Methylphenidate vs placebo
Leaving the study early · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in dropouts compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for apathy in Alzheimer's disease 2018 · Cochrane Headline outcomes onlyRR 2.1 [0.6, 7.38]3 studies · 145 participantsLow